Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its ...

Major stock indexes closed sharply higher for a second straight session Thursday after President Donald Trump reduced tensions with European allies by backing off his threat of imposing new tariffs ...

Abbott Laboratories raised its dividend 7% and targets $5.80 EPS with 19.2x forward P/E and double-digit profit growth. See ...

A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, ...

On Thursday, three companies traded on heavy volume, while their stock prices fell by a meaningful amount. GE Aerospace (GE) ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

The Morning Bull - US Market Morning Update Friday, Jan, 23 2026 US stock futures are slightly softer this morning, with S&P 500 contracts edging lower by around 0.1%, as investors weigh higher ...

Abbott Laboratories reported fourth quarter sales below expectations before the market opened on Jan. 22, sending the stock down nearly 12% from the prior day's closing. The biggest hits came from ...

Abbott reports fourth-quarter sales that miss analysts’ estimates.